Advertisement

Index by author

November 01, 2003; Volume 31,Issue 11

A

  1. Arison, Byron H.

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

  2. Assang, Carol

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

B

  1. Baillie, Thomas A.

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

  2. Benet, Leslie Z.

    1. DISPOSITION OF TACROLIMUS IN ISOLATED PERFUSED RAT LIVER: INFLUENCE OF TROLEANDOMYCIN, CYCLOSPORINE, AND GG918
      Chi-Yuan Wu and Leslie Z. Benet
      Drug Metabolism and Disposition November 2003, 31 (11) 1292-1295; DOI: https://doi.org/10.1124/dmd.31.11.1292

  3. Berry, Loren M.

    1. PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448

  4. Bible, Roy H.

    1. PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448

  5. Braun, Matthew P.

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

  6. Byrnes-Blake, Kelly A.

    1. USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320

C

  1. Cassidy, K. C.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  2. Chappell, Alfred

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

  3. Chatterjee, Parnali

    1. HUMAN CYTOCHROME P450 INHIBITION AND METABOLIC-INTERMEDIATE COMPLEX FORMATION BY GOLDENSEAL EXTRACT AND ITS METHYLENEDIOXYPHENYL COMPONENTS
      Parnali Chatterjee and Michael R. Franklin
      Drug Metabolism and Disposition November 2003, 31 (11) 1391-1397; DOI: https://doi.org/10.1124/dmd.31.11.1391

  4. Cherrington, Nathan J.

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
    2. CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS
      Supratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337

  5. Choudhuri, Supratim

    1. CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS
      Supratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337

  6. Cook, Chyung S.

    1. PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448

  7. Cramer, J. W.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  8. Cui, Donghui

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

  9. Cummins, Len

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

D

  1. Dalvie, Deepak K.

    1. MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN
      John P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott Obach
      Drug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369

  2. Duanmu, Zhengbo

    1. TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378

  3. Dunbar, Debbie

    1. CHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSION
      Qing-Yu Zhang, Debbie Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition November 2003, 31 (11) 1346-1351; DOI: https://doi.org/10.1124/dmd.31.11.1346

F

  1. Fang, Hai-Lin

    1. TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378

  2. Farid, N. A.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  3. Franklin, Michael R.

    1. HUMAN CYTOCHROME P450 INHIBITION AND METABOLIC-INTERMEDIATE COMPLEX FORMATION BY GOLDENSEAL EXTRACT AND ITS METHYLENEDIOXYPHENYL COMPONENTS
      Parnali Chatterjee and Michael R. Franklin
      Drug Metabolism and Disposition November 2003, 31 (11) 1391-1397; DOI: https://doi.org/10.1124/dmd.31.11.1391

  4. Fukumoto, Hiroyuki

    1. METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

  5. Fukushima, Yoko

    1. METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

  6. Furuta, Takashi

    1. EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283

G

  1. Gadberry, M. G.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  2. Gasiewicz, Thomas A.

    1. THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279

  3. Geary, Richard S.

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

  4. Geer, Leslie A.

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

  5. Geng, Wanping

    1. A METHOD FOR IDENTIFICATION OF INHIBITION MECHANISM AND ESTIMATION OF KI IN IN VITRO ENZYME INHIBITION STUDY
      Wanping Geng
      Drug Metabolism and Disposition November 2003, 31 (11) 1456-1457; DOI: https://doi.org/10.1124/dmd.31.11.1456

  6. Gentry, W. Brooks

    1. USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320

  7. Gibson, Christopher R.

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

  8. Greenblatt, David J.

    1. THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306

  9. Grillo, Mark P.

    1. STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
    2. IDENTIFICATION OF ZOMEPIRAC-S-ACYL-GLUTATHIONE IN VITRO IN INCUBATIONS WITH RAT HEPATOCYTES AND IN VIVO IN RAT BILE
      Mark P. Grillo and Fengmei Hua
      Drug Metabolism and Disposition November 2003, 31 (11) 1429-1436; DOI: https://doi.org/10.1124/dmd.31.11.1429

H

  1. Hajdu, Elisabeth

    1. PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448

  2. Halpin, Rita A.

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

  3. Hardee, Greg E.

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

  4. Harmatz, Jerold S.

    1. THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306

  5. Hayakawa, Hiroyoshi

    1. METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

  6. Hazai, Eszter

    1. GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310

  7. Henry, Scott P.

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

  8. Ho, Jonathan Z.

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

  9. Hribar, Jeremy D.

    1. PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448

  10. Hua, Fengmei

    1. STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
    2. IDENTIFICATION OF ZOMEPIRAC-S-ACYL-GLUTATHIONE IN VITRO IN INCUBATIONS WITH RAT HEPATOCYTES AND IN VIVO IN RAT BILE
      Mark P. Grillo and Fengmei Hua
      Drug Metabolism and Disposition November 2003, 31 (11) 1429-1436; DOI: https://doi.org/10.1124/dmd.31.11.1429

  11. Huang, Wendong

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315

I

  1. Ingelman-Sundberg, Magnus

    1. GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310

J

  1. Jackson, D. A.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  2. Jekerle, Veronika

    1. INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
      Shirley Teng, Veronika Jekerle and Micheline Piquette-Miller
      Drug Metabolism and Disposition November 2003, 31 (11) 1296-1299; DOI: https://doi.org/10.1124/dmd.31.11.1296

  3. Joiakim, Aby

    1. THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279

K

  1. Kadota, Takumi

    1. METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

  2. Kalgutkar, Amit S.

    1. MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN
      John P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott Obach
      Drug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369

  3. Kaminsky, Laurence S.

    1. CHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSION
      Qing-Yu Zhang, Debbie Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition November 2003, 31 (11) 1346-1351; DOI: https://doi.org/10.1124/dmd.31.11.1346

  4. Kasuya, Yasuji

    1. EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283

  5. Kato, Hiroshi

    1. METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

  6. Klaassen, Curtis D.

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
    2. CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS
      Supratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337

  7. Knutson, Charles G.

    1. STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327

  8. Kocarek, Thomas A.

    1. TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378

  9. Kuehl, Gwendolyn E.

    1. N-GLUCURONIDATION OF NICOTINE AND COTININE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES
      Gwendolyn E. Kuehl and Sharon E. Murphy
      Drug Metabolism and Disposition November 2003, 31 (11) 1361-1368; DOI: https://doi.org/10.1124/dmd.31.11.1361

  10. Kuroiwa, Hiroyuki

    1. METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

L

  1. Laurenzana, Elizabeth M.

    1. USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320

  2. Levin, Arthur A.

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

  3. Li, Ning

    1. CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS
      Supratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337

  4. Lin, Charles C.

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

  5. Liu, Norman W.

    1. PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448

  6. Lu, Ping

    1. MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
    2. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

M

  1. Ma, Bennett

    1. SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO
      Bennett Ma, Magang Shou and Michael L. Schrag
      Drug Metabolism and Disposition November 2003, 31 (11) 1300-1305; DOI: https://doi.org/10.1124/dmd.31.11.1300

  2. Maher, Jonathan M.

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315

  3. Mathieu, Patricia A.

    1. THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279

  4. Matson, John

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

  5. Mattiuz, E. L.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  6. Milesi-Hallé, Alessandra

    1. USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320

  7. Monostory, Katalin

    1. GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310

  8. Moore, David D.

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315

  9. Mori, Chieko

    1. EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283

  10. Murphy, Sharon E.

    1. N-GLUCURONIDATION OF NICOTINE AND COTININE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES
      Gwendolyn E. Kuehl and Sharon E. Murphy
      Drug Metabolism and Disposition November 2003, 31 (11) 1361-1368; DOI: https://doi.org/10.1124/dmd.31.11.1361

N

  1. Nishigaki, Junko

    1. METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

O

  1. O'Bannon, D. D.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  2. O'Donnell, John P.

    1. MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN
      John P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott Obach
      Drug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369

  3. Obach, R. Scott

    1. MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN
      John P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott Obach
      Drug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369

  4. Owens, S. Michael

    1. USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320

P

  1. Palermo, Christine

    1. THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279

  2. Perkins, E. J.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  3. Piquette-Miller, Micheline

    1. INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
      Shirley Teng, Veronika Jekerle and Micheline Piquette-Miller
      Drug Metabolism and Disposition November 2003, 31 (11) 1296-1299; DOI: https://doi.org/10.1124/dmd.31.11.1296

  4. Pitzenberger, Steven M.

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

  5. Porsmyr-Palmertz, Margareta

    1. GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310

R

  1. Raab, Conrad E.

    1. MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352

  2. Reiners, John J.

    1. THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279

  3. Rodrigues, A. David

    1. MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352

  4. Runge-Morris, Melissa

    1. TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378

S

  1. Sanders, Phillip E.

    1. STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327

  2. Sasmor, Henri

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

  3. Schrag, Michael L.

    1. SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO
      Bennett Ma, Magang Shou and Michael L. Schrag
      Drug Metabolism and Disposition November 2003, 31 (11) 1300-1305; DOI: https://doi.org/10.1124/dmd.31.11.1300
    2. MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352

  4. Shader, Richard I.

    1. THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306

  5. Shenoy, Sarita

    1. TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378

  6. Shibasaki, Hiromi

    1. EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283

  7. Shou, Magang

    1. SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO
      Bennett Ma, Magang Shou and Michael L. Schrag
      Drug Metabolism and Disposition November 2003, 31 (11) 1300-1305; DOI: https://doi.org/10.1124/dmd.31.11.1300
    2. MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352

  8. Silva-Elipe, Maria V.

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

  9. Singh, Rominder

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

  10. Slaughter, Donald

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

  11. Slaughter, Donald E.

    1. MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352

  12. Slitt, Angela L.

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315

  13. Subramanian, Raju

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

  14. Suzuki, Atsushi

    1. EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283

T

  1. Takenaga, Norihiro

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

  2. Tamási, Viola

    1. GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310

  3. Teng, Shirley

    1. INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
      Shirley Teng, Veronika Jekerle and Micheline Piquette-Miller
      Drug Metabolism and Disposition November 2003, 31 (11) 1296-1299; DOI: https://doi.org/10.1124/dmd.31.11.1296

  4. Tsuji, Akira

    1. METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

V

  1. Vereczkey, László

    1. GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310

  2. Von Moltke, Lisa L.

    1. THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306

  3. Vyas, Kamlesh P.

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

W

  1. Waldon, Daniel J.

    1. STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327

  2. Walle, Thomas

    1. THE β-d-GLUCOSIDE AND SODIUM-DEPENDENT GLUCOSE TRANSPORTER 1 (SGLT1)-INHIBITOR PHLORIDZIN IS TRANSPORTED BY BOTH SGLT1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS 1/2
      Thomas Walle and U. Kristina Walle
      Drug Metabolism and Disposition November 2003, 31 (11) 1288-1291; DOI: https://doi.org/10.1124/dmd.31.11.1288

  3. Walle, U. Kristina

    1. THE β-d-GLUCOSIDE AND SODIUM-DEPENDENT GLUCOSE TRANSPORTER 1 (SGLT1)-INHIBITOR PHLORIDZIN IS TRANSPORTED BY BOTH SGLT1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS 1/2
      Thomas Walle and U. Kristina Walle
      Drug Metabolism and Disposition November 2003, 31 (11) 1288-1291; DOI: https://doi.org/10.1124/dmd.31.11.1288

  4. Walsh, Deborah J.

    1. METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

  5. Wan, Yu-Jui Yvonne

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315

  6. Ware, Joseph A.

    1. STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327

  7. Warrington, Jill S.

    1. THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306

  8. Watanabe, Tanya

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

  9. Weiss, H. J.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  10. Wheeler, W. J.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  11. Williams, D. Keith

    1. USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320

  12. Wood, P. G.

    1. PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382

  13. Wu, Chi-Yuan

    1. DISPOSITION OF TACROLIMUS IN ISOLATED PERFUSED RAT LIVER: INFLUENCE OF TROLEANDOMYCIN, CYCLOSPORINE, AND GG918
      Chi-Yuan Wu and Leslie Z. Benet
      Drug Metabolism and Disposition November 2003, 31 (11) 1292-1295; DOI: https://doi.org/10.1124/dmd.31.11.1292

Y

  1. Yamamoto, Hiroyuki

    1. METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

  2. Yergey, James L.

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

  3. Yokokawa, Akitomo

    1. EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283

  4. Yu, Rosie Z.

    1. PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

  5. Yu, Xiao

    1. BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

Z

  1. Zhang, Jun

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315

  2. Zhang, Qing-Yu

    1. CHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSION
      Qing-Yu Zhang, Debbie Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition November 2003, 31 (11) 1346-1351; DOI: https://doi.org/10.1124/dmd.31.11.1346

  3. Zhang, Xiao-Xue

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
Back to top

In this issue